Cargando…
EGFR-Targeted Hybrid Plasmonic Magnetic Nanoparticles Synergistically Induce Autophagy and Apoptosis in Non-Small Cell Lung Cancer Cells
BACKGROUND: The epidermal growth factor receptor (EGFR) is overexpressed in 80% of non-small cell lung cancer (NSCLC) and is associated with poor survival. In recent years, EGFR-targeted inhibitors have been tested in the clinic for NSCLC. Despite the emergence of novel therapeutics and their applic...
Autores principales: | Yokoyama, Tomohisa, Tam, Justina, Kuroda, Shinji, Scott, Ailing W., Aaron, Jesse, Larson, Tim, Shanker, Manish, Correa, Arlene M., Kondo, Seiji, Roth, Jack A., Sokolov, Konstantin, Ramesh, Rajagopal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210119/ https://www.ncbi.nlm.nih.gov/pubmed/22087216 http://dx.doi.org/10.1371/journal.pone.0025507 |
Ejemplares similares
-
EGFR-targeted plasmonic magnetic nanoparticles suppress lung tumor growth by abrogating G2/M cell-cycle arrest and inducing DNA damage
por: Kuroda, Shinji, et al.
Publicado: (2014) -
MDA-7/IL-24 suppresses human ovarian carcinoma growth in vitro and in vivo
por: Gopalan, Began, et al.
Publicado: (2007) -
Tumor Suppressor Gene-Based Nanotherapy: From Test Tube to the Clinic
por: Shanker, Manish, et al.
Publicado: (2011) -
Plasmonic gold nanostars for synergistic photoimmunotherapy to treat cancer
por: Liu, Yang, et al.
Publicado: (2021) -
Radiotherapy plus EGFR inhibitors: synergistic modalities
por: Bossi, Paolo, et al.
Publicado: (2017)